{"transactions":[{"id":352,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-02T20:05:26.000Z","date":"2026-08-31","kind":"grant","planned":false,"acquired":true,"shares":21750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option represents the annual non-employee director equity award to the Reporting Person and shall vest and become exercisable in full on the earlier of (A) August 31, 2027, the one-year anniversary of the date of grant, and (B) the annual meeting of the Issuer's stockholders held in 2027, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. No additional equity award will be made to the Reporting Person in connection with the 2026 annual meeting of stockholders."}],"balance_after":21750,"derivative":{"exercise_price":2.7,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":21750},"source":{"system":"sec-edgar","filing":"0001230486-26-000002","document":"wk-form4_1788379523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1601485/000123048626000002/wk-form4_1788379523.xml","form_type":"4"}},{"id":1140219,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-20T16:06:50.000Z","date":"2025-05-19","kind":"grant","planned":false,"acquired":true,"shares":7900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) May 19, 2026, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after\nthe grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":7900,"derivative":{"exercise_price":5.84,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":7900},"source":{"system":"sec-edgar","filing":"0001601485-25-000087","document":"wk-form4_1747771603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000160148525000087/wk-form4_1747771603.xml","form_type":"4"}},{"id":1352471,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-25T07:37:17.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest and become exercisable in full on the earlier of (A) November 21, 2025, the one-year anniversary of the date of grant and (B) the next annual meeting of the Company's stockholders after the grant date, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":5.12,"expiration_date":"2034-11-21","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001601485-24-000099","document":"wk-form4_1732538230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000160148524000099/wk-form4_1732538230.xml","form_type":"4"}},{"id":1661200,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-02-02T16:42:36.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted share unit award, which shall vest on January 31, 2025, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":423750,"source":{"system":"sec-edgar","filing":"0001415889-24-002328","document":"form4-02022024_090215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000141588924002328/form4-02022024_090215.xml","form_type":"4"}},{"id":1697828,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2023-12-29T17:05:43.000Z","date":"2023-12-28","kind":"grant","planned":false,"acquired":true,"shares":4100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date."}],"balance_after":4100,"derivative":{"exercise_price":8.26,"expiration_date":"2033-12-28","underlying":"Common Stock","underlying_shares":4100},"source":{"system":"sec-edgar","filing":"0001140361-23-060234","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000114036123060234/form4.xml","form_type":"4"}},{"id":1756836,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2023-10-20T16:22:52.000Z","date":"2023-10-19","kind":"grant","planned":false,"acquired":true,"shares":56600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The option grant was approved by the Board of Directors of the Issuer on February 8, 2023, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on October 19, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":56600,"derivative":{"exercise_price":1.59,"expiration_date":"2033-10-18","underlying":"Ordinary Shares","underlying_shares":56600},"source":{"system":"sec-edgar","filing":"0001209191-23-053245","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000120919123053245/doc4a.xml","form_type":"4/A","original_submission_date":"2023-02-10"}},{"id":1756835,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-10-20T16:22:52.000Z","date":"2023-10-19","kind":"grant","planned":false,"acquired":true,"shares":28300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") award was approved by the Board of Directors of the Issuer on February 8, 2023, subject to shareholder approval. The Issuer's shareholders approved the award at the annual general meeting of the shareholders on October 19, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an RSU award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":223750,"source":{"system":"sec-edgar","filing":"0001209191-23-053245","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000120919123053245/doc4a.xml","form_type":"4/A","original_submission_date":"2023-02-10"}},{"id":2022407,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2023-02-10T19:21:24.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":56600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on May 8, 2023, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":56600,"derivative":{"exercise_price":1.59,"expiration_date":"2033-02-07","underlying":"Ordinary Shares","underlying_shares":56600},"source":{"system":"sec-edgar","filing":"0001209191-23-008537","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000120919123008537/doc4.xml","form_type":"4"}},{"id":2022406,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-02-10T19:21:24.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":28300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted share unit award, which shall vest on February 8, 2024, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":223750,"source":{"system":"sec-edgar","filing":"0001209191-23-008537","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000120919123008537/doc4.xml","form_type":"4"}},{"id":2106725,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Option (Right to Buy)","published_at":"2022-11-22T16:32:32.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in equal quarterly installments over a twelve-month period, with the first such installment vesting on February 1, 2023, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":9500,"derivative":{"exercise_price":1.79,"expiration_date":"2032-11-17","underlying":"Ordinary Shares","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001209191-22-058386","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000120919122058386/doc4.xml","form_type":"4"}},{"id":2106724,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-11-22T16:32:32.000Z","date":"2022-11-18","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted share unit award, which shall vest on November 1, 2023, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":195450,"source":{"system":"sec-edgar","filing":"0001209191-22-058386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000120919122058386/doc4.xml","form_type":"4"}},{"id":2189205,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2022-08-10T16:58:13.000Z","date":"2022-07-27","kind":"grant","acquired":true,"shares":291100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F4","text":"The option grant was approved by the Board of Directors of the Issuer on January 28, 2022, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on July 27, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One fourth (1/4th) of the shares subject to the option award shall vest on July 27, 2023, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":291100,"derivative":{"exercise_price":2.93,"expiration_date":"2032-07-26","underlying":"Ordinary Shares","underlying_shares":291100},"source":{"system":"sec-edgar","filing":"0001209191-22-045234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000120919122045234/doc4.xml","form_type":"4"}},{"id":2189204,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-10T16:58:13.000Z","date":"2022-07-27","kind":"grant","acquired":true,"shares":68800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") award was approved by the Board of Directors of the Issuer on January 28, 2022, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on July 27, 2022."},{"field":"shares","element":"transactionShares","label":"F3","text":"These shares represent an RSU award, which shall vest in two equal annual installments commencing on December 31, 2022. The vesting of the RSUs is subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":193450,"source":{"system":"sec-edgar","filing":"0001209191-22-045234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000120919122045234/doc4.xml","form_type":"4"}},{"id":2189203,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2022-08-10T16:58:13.000Z","date":"2022-07-27","kind":"grant","acquired":true,"shares":48500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The restricted stock unit (\"RSU\") award was approved by the Board of Directors of the Issuer on January 28, 2022, subject to shareholder approval. The Issuer's shareholders approved the grant at the annual general meeting of the shareholders on July 27, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"These shares represent an RSU award, which shall vest in three equal annual installments commencing on July 27, 2023. The vesting of the RSUs is subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":124650,"source":{"system":"sec-edgar","filing":"0001209191-22-045234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000120919122045234/doc4.xml","form_type":"4"}},{"id":4086286,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-29T16:40:30.000Z","date":"2018-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in four equal installments on each of March 31, June 30, September 30 and December 31, 2018."}],"balance_after":20000,"derivative":{"exercise_price":7.72,"expiration_date":"2028-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-18-000483","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000156218018000483/primarydocument.xml","form_type":"4"}},{"id":4477076,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-01-30T19:04:10.000Z","date":"2017-01-25","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in four equal installments on each of March 31, June 30, September 30, and December 31, 2017."}],"balance_after":20000,"derivative":{"exercise_price":2.01,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-17-002205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1230486/000089924317002205/doc4.xml","form_type":"4"}},{"id":4569570,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":345,"kind":"person","name":"ADAMS JULIAN","position":1,"cik":"0001230486","reported_name":"ADAMS JULIAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President of R&D"}}],"security":"Common Stock","published_at":"2016-11-02T16:56:06.000Z","date":"2016-10-31","kind":"grant","acquired":true,"shares":59150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares from a grant of performance-based restricted stock on July 22, 2016. Upon the determination by the Compensation Committee of our Board of Directors, such shares vested in full on October 31, 2016."}],"balance_after":59150,"source":{"system":"sec-edgar","filing":"0000899243-16-032622","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924316032622/doc4.xml","form_type":"4"}}]}